Mitsu Chem Plast

- Mitsu Chem Plast is actively pursuing capacity expansion with a recently announced Unit 4 plant adding 900 metric tons of capacity. - Current capacity is about 29,000 metric tons; to achieve INR1,000 crore turnover, capacity will need to roughly double. - Capex for expansion is expected to be significant but specifics are yet to be finalized and will be announced piecemeal once approved. - Machinery procurement and installation timelines are around 4 to 6 months. - Plans for further plant expansion beyond Unit 4 are in progress but not finalized. - No immediate intention for a rights issue to fund Unit 4 capex, but options remain open depending on circumstances. - The company aims to continue investing in both niche and commodity product lines to support growth targets.

- Mitsu Chem Plast aims to reach INR 1,000 crores revenue by FY '28, implying a 35%-40% CAGR, higher than historical ~18%-19% growth. - Current utilization is around 65% with a maximum practical capacity utilization of 85%-90%. - To achieve INR 1,000 crores, the company expects to roughly double its capacity from the current ~29,000 metric tons. - Capex plans include ongoing machinery expansions (Unit 4) and land acquisition for new plants; exact investments to be announced once finalized. - Sales growth will be gradual, supported by building customer relationships, expanding niche product share (expected to remain around 15%-20%), and focusing on higher-margin products. - Export potential is positive, targeting Europe, Canada, and Gulf markets with niche products. - FY '27 revenue expected to grow modestly, with focus on profitability over volume spike. - Significant ramp-up in sales expected post capacity expansions and operational scale-up.

- Mitsu Chem Plast Limited targets INR1,000 crore annual revenue by FY 2028, implying a significant growth trajectory. - EBITDA margins expected to remain around 8%-10% currently, with potential margin improvement as scale and operational efficiencies increase. - Net profit and EPS have shown strong YoY growth: Q3 FY26 net profit rose by 217%, EPS by 218%. - Operating efficiency, better sales realization, and improved product mix are key drivers of margin expansion. - The company aims for gradual ramp-up of sales, focusing on niche products (~15%-20% mix at INR1,000 crore scale) alongside commodity products. - Expansion plans include doubling capacity, supported by ongoing machinery additions and new plants (Unit 4 announced), to fuel growth. - They expect profitability and EBITDA margins to improve with scale, innovation, and enhanced operational excellence by FY 28. - Export expansion and higher value-added segments like healthcare furniture component Furnastra are growth levers.

The transcript provided does not specifically mention the current or expected order book or pending orders for Mitsu Chem Plast Limited. However, relevant insights from the discussion include: - Orders in the industry are generally short-term, typically not more than one month due to frequent price fluctuations. - Repeat orders constitute approximately 65% to 70% of sales, indicating a steady base of recurring business. - Export orders have passed approvals in 17 countries, with expectations of significant growth, especially in Europe. - The company is actively expanding capacity (including Unit 4) to meet growing demand and increase turnover. - Customer concentration is spread across 30-35 customers contributing to 80% of business, indicating diversified order sources. No explicit quantitative data on current or expected order book or backlog is provided in the transcript.

- As of the latest call (February 02, 2026), Mitsu Chem Plast Limited has around INR 63-64 crores of current debt. - There is no immediate plan for a rights issue or new equity fundraising for the Unit 4 plant expansion, but they remain open to possibilities depending on how things progress. - The company is yet to finalize detailed capex plans for capacity expansion aimed at reaching INR 1,000 crores turnover; announcements will be made once finalized and approved by the board. - Funding for expansion will likely focus more on machinery and plant expansion, with gradual announcements going forward. - The management did not explicitly rule out equity fundraising but suggested that as of now, they do not anticipate it.